The new CMS initiative dubbed CRUSH aims at cracking down on potentially fraudulent orders for molecular diagnostic tests and ...
The updated analyst narrative on Insight Molecular Diagnostics now centers on a fresh price target of $12 per share, while the internal fair value estimate remains at $8.33. Analysts linking this move ...
The global molecular diagnostics market is projected to reach USD 33.51 billion by 2031, driven by expanding precision medicine adoption and advanced genetic testing. North America leads the market, ...
Dipylon Medical Expands Access to Clinical Microbiology Equipment for Modern Diagnostic Laboratories
Expanding access to advanced PCR thermocyclers, DNA & RNA purification systems, and hematology analyzers for modern clinical laboratories SINGAPORE, SG / ACCESS Newswire / March 7, 2026 / Dipylon ...
(Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that the Japan Patent ...
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission
Three-site reproducibility study completed by Tampa General Hospital, Mayo Clinic, and Baylor Scott & White HealthSufficient clinical samples ...
In oncology care, respiratory can pose serious risks—especially when diagnostic delays disrupt treatment decisions. Yet many clinical labs still rely | Ebooks ...
When Domain Associates led Xagenic Inc.’s recent $20 million Series B, it marked the eighth diagnostics investment the firm had made with its $500 million eighth fund. The partners say they’ve ...
IMDX is trading in the middle of its 52-week range and above its 200-day simple moving average. Price change The price of IMDX shares has decreased $0.10 since the market last closed. This is a 1.74% ...
In the following sections, we highlight ethical concerns about early adoption of molecular diagnostic testing without solid evidence or guidelines and offer practical guidance for ethical ...
New data supports GraftAssure commercialization effortsMulti-center study featured 249 biopsy-matched patientsProprietary "Combination Model" score outperformed percentage-only measures of dd-cfDNARei ...
DELRAY BEACH, Fla., Feb. 10, 2026 /PRNewswire/ -- According to MarketsandMarkets (TM), the Tissue Diagnostics Market is projected to grow from about USD 6.74 billion in 2025 to USD 10.86 billion by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results